NuScale Reports Strong Q4 and Full-Year 2025 Results, Advances SMR Commercialization

NuScale reported a heavy 2025 net shortfall alongside a cash cushion intended to carry its SMR push forward. Consolidated net loss was $(664,462) (in thousands), equal to about $664.462 million, even as reported liquidity grew to $1.3 billion and the company stressed that cash will fund supply chain and commercialization readiness.

Topline revenue weakened. Full-year 2025 revenue totaled $31.5 million versus $37.0 million in 2024, a drop of roughly 14.9 percent. Fourth-quarter revenue was $1.81 million, well below the $8.76 million expectation cited by one market data provider, and Q4 earnings per share came in at ($0.80) versus a ($0.10) consensus, a $0.70 miss that highlights ongoing profitability pressure.

Expense items explain much of the headline volatility. NuScale reported general and administrative expense of $609.8 million for 2025 compared with $75.9 million in 2024, driven primarily by recognition of “Milestone Contribution 1” of $507.4 million under its Partnership Milestone Agreement with ENTRA1, plus $14.6 million of strategic business development costs and $11.8 million of advisory, legal and accounting fees. Cost of sales rose to $20.0 million from $4.9 million a year earlier, a change the company attributes to engineering services required by Fluor under FEED Phase 2 with RoPower; the company also notes licensing revenue under the technology license agreement carries no cost of sales.

Balance sheet details underline how NuScale is prioritizing runway over near-term profit. Cash and cash equivalents were $836,417 (in thousands), short-term investments $417,800, restricted cash $5,100 and prepaid expenses $4,877 on the consolidated balance sheet. Accounts and other receivables, net appear in the filing with tabulated totals of $8,378 for 2025 and $21,104 for 2024, alongside a parenthetical line showing $5,452 for 2025 and $3,655 in 2024 from a related party, a formatting presentation the filing leaves ambiguous. CFO Ramsey Hamady said the strengthened liquidity will support supply chain and manufacturing readiness and fund commercialization obligations, and the company added, “NuScale expects revenues from products and services to support positive cash flow from operations as projects move forward.”

Commercialization momentum remains the strategic headline. CEO John Hopkins said, “For NuScale, 2025 was a breakthrough year, in which we further solidified our position as the SMR industry’s first mover.” He further noted ENTRA1 has reached a nonbinding collaborative agreement with TVA to pursue deployment of up to 6 gigawatts of NuScale SMR capacity across TVA’s seven-state service region, and highlighted that NuScale is the first and only SMR technology to receive NRC design approval for the uprated 77 MWe NuScale Power Module.

The market’s response was muted skepticism. One market data feed reported NuScale shares fell 1.9 percent in aftermarket trading to $12.93, trading near a 52-week low of $11.08 and down roughly 63 percent over six months, with investors flagging the revenue miss and the lack of binding project contracts.

Not all third-party summaries line up with the company filing. One data provider framed operating expenses as “steady between $172 million and $200 million annually,” a range that conflicts with the company’s $609.8 million G&A disclosure driven by the $507.4 million milestone recognition. Analysts and buyers watching NuScale now will be looking for conversion of nonbinding ENTRA1–TVA plans into binding contracts and the timing of service revenue from FEED and construction activity to validate the company’s assertion that product and service revenues will bend operations toward positive cash flow.